‘Multimorbidity’ as the manifestation of network disturbances

Journal of Evaluation in Clinical Practice

Volumn 23, Issue 1, 2017, Pages 199-208

  Sturmberg, Joachim P ^a   Bennett, Jeanette M ^b   Martin, Carmel M ^c   Picard, Martin ^d  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b UNIVERSITY OF NORTH CAROLINA AT CHARLOTTE   (United States)

^c SOUTHERN HEALTH   (Australia)

^d Columbia University Medical Center ^*  (United States)

Author keywords

complex adaptive systems; mitochondria; multimorbidity; nonlinear dynamics; philosophy of health; philosophy of medicine; psychoneuroimmunology

Indexed keywords

ARTICLE; CASE STUDY; CELL ENERGY; CYTOKINE PRODUCTION; HEALTH CARE NEED; HEALTH CARE PERSONNEL; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INTEGRATED HEALTH CARE SYSTEM; MORBIDITY; MULTIMORBIDITY; NEUROENDOCRINE SYSTEM; PERSONAL EXPERIENCE; PERSONALIZED MEDICINE; SOCIAL NETWORK; SOCIAL PSYCHOLOGY; ENVIRONMENT; GENOMICS; HEALTH CARE DELIVERY; MEDICAL RESEARCH; MULTIPLE CHRONIC CONDITIONS; ORGANIZATION AND MANAGEMENT; PHILOSOPHY; SOCIAL ENVIRONMENT; SOCIOECONOMICS; STANDARDS;

BIOMEDICAL RESEARCH; DELIVERY OF HEALTH CARE; ENVIRONMENT; GENOMICS; HOLISTIC HEALTH; HUMANS; MULTIPLE CHRONIC CONDITIONS; SOCIAL ENVIRONMENT; SOCIOECONOMIC FACTORS;

EID: 84978636813     PISSN: 13561294     EISSN: 13652753     Source Type: Journal    
DOI: 10.1111/jep.12587     Document Type: Article

References (90)

1. Loscalzo, J., Kohane, I. & Barabasi, A.-L. (2007) Human disease classification in the postgenomic era: a complex systems approach to human pathobiology. Molecular Systems Biology, 3, 124.
2. Sturmberg, J. P. & Martin, C. M. (2016) Diagnosis – the limiting focus of taxonomy. Journal of Evaluation in Clinical Practice, 22 (1), 103–111.
3. van den Akker, M., Buntinx, F. & Knottnerus, J. A. (1996) Comorbidity or multimorbidity. European Journal of General Practice, 2 (2), 65–70.
4. Goh, K.-I., Cusick, M. E., Valle, D., Childs, B., Vidal, M. & Barabási, A.-L. (2007) The human disease network. Proceedings of the National Academy of Science, 104 (21), 8685–8690.
5. Tracey, K. J. (2007) Physiology and immunology of the cholinergic antiinflammatory pathway. Journal of Clinical Investigation, 117 (2), 289–296.
6. Glaser, R. & Kiecolt-Glaser, J. K. (2005) Stress-induced immune dysfunction: implications for health. Nature Reviews Immunology, 5, 243–251.
7. Cole, S. W. (2013) Social regulation of human gene expression: mechanisms and implications for public health. American Journal of Public Health, 103 (S1), S84–S92.
8. Picard, M., Juster, R. P. & McEwen, B. S. (2014) Mitochondrial allostatic load puts the 'gluc' back in glucocorticoids. Nature Reviews Endrocrinology, 10 (5), 303–310.
9. Wallace, D. C. (2013) A mitochondrial bioenergetic etiology of disease. Journal of Clinical Investigation, 123 (4), 1405–1412.
10. Barabási, A.-L. (2007) Network medicine – from obesity to the “diseasome”. New England Journal of Medicine, 357 (4), 404–407.
11. Moynihan, R., Glasziou, P., Woloshin, S., Schwartz, L., Santa, J. & Godlee, F. (2013) Winding back the harms of too much medicine. British Medical Journal, 346 f1271.
12. Tinetti, M. E. & Fried, T. (2004) The end of the disease era. American Journal of Medicine, 16 (3), 179–185.
13. Heng, H. H. Q., Liu, G., Stevens, J. B., Bremer, S. W., Ye, K. J., Abdallah, B. Y., Horne, S. D. & Ye, C. J. (2011) Decoding the genome beyond sequencing: the new phase of genomic research. Genomics, 98 (4), 242–252.
14. Cannon, W. B. (1935) Stresses and strains of homeostasis. American Journal of Medical Science, 189, 1–14.
15. Goldberger, A. L., Amaral, L. A. N., Hausdorff, J. M., Ivanov, P. C., Peng, C.-K. & Stanley, H. E. (2002) Fractal dynamics in physiology: alterations with disease and aging. Proceedings of the National Academy of Sciences of the United States of America, 99 (Suppl 1), 2466–2472.
16. Billman, G. E. (2013) Homeostasis: the dynamic self-regulatory process that maintains health and buffers against disease. In Handbook of Systems and Complexity in Health (eds J. P. Sturmberg & C. M. Martin), pp. 159–170. New York: Springer.
17. Que, C.-L., Kenyon, C. M., Olivenstein, R., Macklem, P. T. & Maksym, G. N. (2001) Homeokinesis and short-term variability of human airway caliber. Journal of Applied Physiology, 91 (3), 1131–1141.
18. Remick, D. G. & Friedland, J. S. (1997) Cytokines in Health and Disease. New York: M. Dekker.
19. Petrovsky, N. & Harrison, L. C. (1998) The chronobiology of human cytokine production. International Reviews of Immunology, 16, 635–649.
20. Sapolsky, R., Rivier, C. & Yamamoto, G. (1987) Interleukin-1 stimulates the secretion of hypothalmic corticotropin-releasing factor. Science, 238, 522–526.
21. Dantzer, R. (2004) Innate immunity at the forefront of psychoneuroimmunology. Brain, Behavior, and Immunity, 18 (1), 1–6.
22. Dantzer, R. & Kelley, K. W. (2007) Twenty years of research on cytokine-induced sickness behavior. Brain, Behavior, and Immunity, 21 (2), 153–160.
23. Watkins, L. R. & Maier, S. F. (1999) Implications of immune-to-brain communication for sickness and pain. Proceedings of the National Academy of Sciences of the United States of America, 96, 7710–7713.
24. Banks, W. A. & Erickson, M. A. (2010) The blood–brain barrier and immune function and dysfunction. Neurobiology of Disease, 37 (1), 26–32.
25. Lazarus, R. S. & Folkman, S. (1984) Stress, Appraisal, and Coping. New York: Springer.
26. Galli, S. J., Tsai, M. & Piliponsky, A. M. (2008) The development of allergic inflammation. Nature, 454 (7203), 445–454.
27. Kargi, A. Y. & Iacobellis, G. (2014) Adipose tissue and adrenal glands: novel pathophysiological mechanisms and clinical applications. International Journal of Endocrinology, 2014 (3), 614074. doi: 10.1155/2014/614074.
28. Kershaw, E. E. & Flier, J. S. (2004) Adipose tissue as an endocrine organ. The Journal of Clinical Endocrinology & Metabolism, 89 (6), 2548–2556.
29. Reaven, G. M. (1988) Role of insulin resistance in human disease. Diabetes, 37 (12), 1595–1607.
30. Bastard, J.-P., Maachi, M., Lagathu, C., Kim, M. J., Caron, M., Vidal, H., Capeau, J. & Feve, B. (2006) Recent advances in the relationship between obesity, inflammation, and insulin resistance. European Cytokine Network, 17 (1), 4–12.
31. Getz, G. S. (2005) Thematic review series: the immune system and atherogenesis. Immune function in atherogenesis. Journal of Lipid Research, 46 (1), 1–10.
32. Hansson, G. K. & Hermansson, A. (2011) The immune system in atherosclerosis. Nature Immunology, 12 (3), 204–212.
33. Berenbaum, F. (2013) Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!). Osteoarthritis and Cartilage, 21 (1), 16–21.
34. Haseeb, A. & Haqqi, T. M. (2013) Immunopathogenesis of osteoarthritis. Clinical Immunology, 146 (3), 185–196.
35. Scanzello, C. R. & Goldring, S. R. (2012) The role of synovitis in osteoarthritis pathogenesis. Bone, 51 (2), 249–257.
36. Picard, M. (2011) Pathways to aging: the mitochondrion at the intersection of biological and psychosocial sciences. Journal of Aging Research, 2011, 11.
37. Naik, E. & Dixit, V. M. (2011) Mitochondrial reactive oxygen species drive proinflammatory cytokine production. Journal of Experimental Medicine, 208 (3), 417–420.
38. Picard, M. & McEwen, B. S. (2014) Mitochondria impact brain function and cognition. Proceedings of the National Academy of Science, 111 (1), 7–8.
39. McEwen, B. S. (2012) Brain on stress: how the social environment gets under the skin. Proceedings of the National Academy of Science, 109 (Supplement 2), 17180–17185.
40. McEwen, B. S. (1998) Protective and damaging effects of stress mediators. New England Journal of Medicine, 338 (3), 171–179.
41. Juster, R.-P., Seeman, T., Bruce, S., et al. (2016) Social inequalities and the road to allostatic load: from vulnerability to resilience. In Developmental Psychopathology. 4 – Risk, Resilience and Intervention (eds D. Cicchetti & D. J. Cohen), 3rd edn. Hobeken, NJ: John Wiley & Sons.
42. Patterson, T., Shaw, W., Semple, S., Cherner, M., McCutchan, A., Atkinson, H., Grant, I. & Nannis, E. (1996) Relationship of psychosocial factors to HIV disease progression. Annals of Behavioral Medicine, 18, 30–39.
43. Leserman, J. (2003) HIV disease progression: depression, stress, and possible mechanisms. Biological Psychiatry, 54 (3), 295–306.
44. Slavich, G. M. & Cole, S. W. (2013) The emerging field of human social genomics. Clinical Psychological Science, 1 (3), 331–348.
45. Slavich, G. M. & Irwin, M. R. (2014) From stress to inflammation and major depressive disorder: a social signal transduction theory of depression. Psychological Bulletin, 140 (3), 774–815.
46. Cohen, S., Doyle, W. & Baum, A. (2006) Socioeconomic status is associated with stress hormones. Psychosomatic Medicine, 68 (3), 414.
47. Wilkinson, R. G. & Pickett, K. (2009) The Spirit Level: Why More Equal Societies Almost Always Do Better. London, UK: Allen Lane.
48. Adler, N. & Rehkopf, D. (2008) US disparities in health: descriptions, causes, and mechanisms. Annual Review of Public Health, 29 (1), 235.
49. Novack, D., Cameron, O., Epel, E., Ader, R., Waldstein, S., Levenstein, S., Antoni, M. H. & Wainer, A. R. (2007) Psychosomatic medicine: the scientific foundation of the biopsychosocial model. Academic Psychiatry, 31 (5), 388–401.
50. Kemeny, M. (2011) Psychoneuroimmunology. In Oxford Handbook of Health Psychology (ed. H. Friedman), pp. 138–161. New York: Oxford University Press.
51. Shapiro, D., Cook, I. A., Davydov, D. M., Ottaviani, C., Leuchter, A. F. & Abrams, M. (2007) Yoga as a complementary treatment of depression: effects of traits and moods on treatment outcome. Evidence-based Complementary and Alternative Medicine, 4 (4), 493–502.
52. Bower, J. E., Greendale, G., Crosswell, A. D., Garet, D., Sternlieb, B., Ganz, P. A., Irwin, M. R., Olmstead, R., Arevalo, J. & Cole, S. W. (2014) Yoga reduces inflammatory signaling in fatigued breast cancer survivors: a randomized controlled trial. Psychoneuroendocrinology, 43, 20–29.
53. Kiecolt-Glaser, J. K., Bennett, J. M., Andridge, R. R., Peng, J., Shapiro, C. L., Marlarkey, W. B., Emery, C. F., Layman, R., Mrozek, E. E. & Glaser, R. (2014) Yoga's impact on inflammation, mood, and fatigue in breast cancer survivors: a randomized controlled trial. Journal of Clinical Oncology, 32 (10), 1040–1049.
54. Mols, F., Vingerhoets, A. J. J. M., Coebergh, J. W. & van de Poll-Franse, L. V. (2005) Quality of life among long-term breast cancer survivors: a systematic review. European Journal of Cancer, 41 (17), 2613–2619.
55. Osborn, R. L., Demoncada, A. C. & Feuerstein, M. (2006) Psychosocial interventions for depression, anxiety, and quality of life in cancer survivors: meta-analyses. The International Journal of Psychiatry in Medicine, 36 (1), 13–34.
56. Kodner, D. L. (2006) Whole-system approaches to health and social care partnerships for the frail elderly: an exploration of North American models and lessons. Health & Social Care in the Community, 14 (5), 384–390.
57. Martin, C. M., Vogel, C., Grady, D., Zarabzadeh, A., Hederman, L., Kellett, J., Smith, K. & O'Shea B. (2012) Implementation of complex adaptive chronic care: the Patient Journey Record system (PaJR). Journal of Evaluation in Clinical Practice, 18 (6), 1226–1234.
58. Cohen, S., Janicki-Deverts, D., Doyle, W. J., Miller, G. E., Frank, E., Rabin, B. S., Turner, R. B. (2012) Chronic stress, glucocorticoid receptor resistance, inflammation, and disease risk. Proceedings of the National Academy of Sciences of the United States of America, 109 (16), 5995–5999.
59. Sturmberg, J. P. (2014) Health: a personal complex-adaptive state. In Handbook of Systems and Complexity in Health (eds J. P. Sturmberg & C. M. Martin), pp. 231–242. New York: Springer.
60. Holman, H. R. (2005) Chronic disease and the healthcare crisis. Chronic Illness, 1 (4), 265–274.
61. Idler, E. L. & Benyamini, Y. (1997) Self-rated health and mortality: a review of twenty-seven community studies. Journal of Health and Social Behavior, 38 (1), 21–37.
62. Jylhä, M. (2009) What is self-rated health and why does it predict mortality? Towards a unified conceptual model. Social Science and Medicine, 69 (3), 307–316.
63. Picard, M., Juster, R. & Sabiston, C. (2013) Is the whole greater than the sum of the parts? Self-rated health and transdisciplinarity. Health Affairs, 5 (12A), 24–30.
64. Jarczok, M. N., Kleber, M. E., Koenig, J., Loerbroks, A., Herr, R. M., Hoffmann, K., Fischer, J. E., Benyamini, Y. & Thayer J. F. (2015) Investigating the associations of self-rated health: heart rate variability is more strongly associated than inflammatory and other frequently used biomarkers in a cross sectional occupational sample. PLoS One, 10 (2e0117196).
65. Bower, P., Macdonald, W., Harkness, E., Gask, L., Kendrick, T., Valderas, J. M., Dickens, C., Blakeman, T. & Sibbald, B. (2011) Multimorbidity, service organization and clinical decision making in primary care: a qualitative study. Family Practice, 28 (5), 579–587.
66. Gill, A., Kuluski, K., Jaakkimainen, L., Naganathan, G., Upshur, R. & Walter, P. W. (2014) "Where do we go from here?" Health system frustrations expressed by patients with multimorbidity, their caregivers and family physicians. Healthcare Policy, 9 (4), 73–89.
67. Trikalinos, T., Segal, J. & Boyd, C. (2014) Addressing multimorbidity in evidence integration and synthesis. Journal of General Internal Medicine, 29 (4), 661–669.
68. Heng, H. H. Q. (2008) The conflict between complex systems and reductionism. JAMA, 300 (13), 1580–1581.
69. Salisbury, C. (2012) Multimorbidity: redesigning health care for people who use it. The Lancet, 380 (9836), 7–9.
70. Fernandez, A., Sturmberg, J., Madden, R., Lukersmith, S., Torkfar, G., Colagiuri, R., & Salvador-Carulla, L. (2015) Evidence-based medicine: is it a bridge too far?. Health Research Policy and Systems, 13, 66. doi: 10.1186/s12961-015-0057-0.
71. Virchow, R. (1941) Die Medizinische Reform, 2. In Medicine and Human Welfare (ed. H. E. Sigerist), pp. 93. New Haven, CT: Yale University Press.
72. Barnett, K., Mercer, S. W., Norbury, M., Watt, G., Wyke, S. & Guthrie, B. (2012) Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. The Lancet, 380 (9836), 37–43.
73. Economos, C. D. & Curtatone, J. A. (2010) Shaping up Somerville: a community initiative in Massachusetts. Preventive Medicine, 50 (Suppl 1), S97–S98.
74. Sturmberg, J. P., Bennett, J. M., Picard, M. & Seely, A. J. E. (2015) The trajectory of life. Decreasing physiological network complexity through changing fractal patterns. Frontiers in Physiology, 6, 169.
75. Starfield, B. (2006) Threads and yarns: weaving the tapestry of comorbidity. Annals of Family Medicine, 4 (2), 101–103.
76. Sturmberg, J. P. (2012) Caring for people with chronic disease: is ‘muddling through’ the best way to handle the multiple complexities? Journal of Evaluation in Clinical Practice, 18 (6), 1220–1225.
77. Husserl, E. (1975) Experience and Judgment. Chicago: Northwestern University Press.
78. Scott, J. G., Cohen, D., DiCicco-Bloom, B., Miller, W. L., Stange, K. C. & Crabtree, B. F. (2008) Understanding healing relationships in primary care. Annals of Family Medicine, 6 (4), 315–322.
79. Della Mea, V., Vuattolo, O., Celik, C. & Ustun, B. (2013) Social network integration of the ICD11 revision platform. Studies in Health Technology and Informatics, 192, 1110.
80. Scadding, J. G. (1996) Essentialism and nominalism in medicine: logic of diagnosis in disease terminology. Lancet, 348 (9027), 594–596.
81. Tikkinen, K. A. O., Leinonen, J. S., Guyatt, G. H., Ebrahim, S. & Järvinen, T. L. N. (2012) What is a disease? Perspectives of the public, health professionals and legislators. BMJ Open, 2 (6).
82. Gems, D. (2015) The aging-disease false dichotomy: understanding senescence as pathology. Frontiers in Genetics, 6, 212. doi: 10.3389/fgene.2015.00212.
83. Soodak, H. & Iberall, A. (1978) Homeokinetics: a physical science for complex systems. Science, 201 (4356), 579–582.
84. Waddington, C. & Egger, D. Integrated Health Services – What and Why? Geneva: WHO Working Group on Service Delivery. Technical Brief No.1, 2008.
85. Shaw, S., Rosen, R. & Rumbold, B. (2011) What is Integrated Care? London: Nuffield Trust.
86. Feinstein, A. R. (1970) The pre-therapeutic classification of co-morbidity in chronic disease. Journal of Chronic Diseases, 23 (7), 455–468.
87. Australian Institute of Health and Welfare (2012) Risk Factors Contributing to Chronic Disease. Canberra. Contract No.: Cat. no. PHE 157. Available at: http://www.aihw.gov.au/WorkArea/DownloadAsset.aspx?id=10737421546 (last accessed 22 June 2016).
88. Sturmberg, J. P. (2014) Multimorbidity and chronic disease: an emergent perspective. Journal of Evaluation in Clinical Practice, 20 (4), 508–512.
89. Martin, C. M. (2016) Multimorbidity – through a glass darkly. In The Value of Systems and Complexity Sciences for Healthcare – Proceedings of the 1st International Conference of Systems and Complexity in Health (ed. J. P. Sturmberg), pp. 121–131. New York: Springer.
90. Schwartz, S. S., Epstein, S., Corkey, B. E., Grant, S. F. A., Gavin, J. R. & Aguilar, R. B. (2016) The time is right for a new classification system for diabetes: rationale and implications of the β-cell–centric classification schema. Diabetes Care, 39 (2), 179–186.